Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Ifosfamide and Topotecan in SCLC
NCT00004186Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 1996
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in small cell lung cancer (SCLC), sponsored by University of Alabama at Birmingham. Started Dec 1996; status: completed.
02
Drugs
topotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00004186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004186.